Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients
Back to article page
|Updated:2021-08-27
|
Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients
Chinese Journal of Integrative MedicineVol. 6, Issue 1, Pages: 6-9(2000)
Affiliations:
1. General Hospital of Jinan Military Region,Jinan
2. The Affiliated Hospital of Shandong University of TCM,china
Wu, Y., Yang, J., Jiang, L. et al. Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients., CJIM 6, 6–9 (2000). https://doi.org/10.1007/BF02973135
Yusheng Wu, Jianhui Yang, Liping Jiang, et al. Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients. [J]. Chinese Journal of Integrative Medicine 6(1):6-9(2000)
Wu, Y., Yang, J., Jiang, L. et al. Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients., CJIM 6, 6–9 (2000). https://doi.org/10.1007/BF02973135DOI:
Yusheng Wu, Jianhui Yang, Liping Jiang, et al. Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients. [J]. Chinese Journal of Integrative Medicine 6(1):6-9(2000) DOI: 10.1007/BF02973135.
Effect of buyang huanwu decoction on plasma thromboxane b2, 6-keto-prostaglandin f1α, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients
摘要
Objective: To explore the mechanism of Buyang Huanwu Decoction (BYHWD) in treating primary nephrotic syndrome (PNS).Methods: Based on the treatment of prednisone acetate and cytoxan
two groups of PNS patients were treated with aspirin and persantin (western medicine group
WM
35 patients) and BYHWD plus WM (TCM-WM group
35 patients) respectively. The effect on anticoagulation was observed and compared. Plasma levels of thromboxane B2 (TXB2 )
6-keto-prostaglandin F1α (6-K-PGF1α)
endothelin (ET)
calcitonin gene related peptide (CGRP) were determined before and after treatment
at the reducing dose and shifting to maintenance dose of prednisone. The therapeutic effect of the two groups were also observed. Another group of 30 healthy subjects was established for control.Results: The differences of TXB2
6-K-PGF1α
ET and CGRP between patients and healthy subjects were very significant before treatment (P < 0. 001). The above-mentioned 4 parameters improved synchronously with the clinical improvement in the therapeutic course and they were better in the TCM-WM group than those in the WM group (P < 0.001 )
and the complete remission rate of the former group was also higher than that of the latter (62.9 % vs 37.1 %
χ2 = 4.63
P < 0.05).Conclusion: BHD could improve the therapeutic effect in treating PNS through the mechanism of improving TXB2
6-K-PGF1α
ET and CGRP levels.
Abstract
Objective: To explore the mechanism of Buyang Huanwu Decoction (BYHWD) in treating primary nephrotic syndrome (PNS).Methods: Based on the treatment of prednisone acetate and cytoxan
two groups of PNS patients were treated with aspirin and persantin (western medicine group
WM
35 patients) and BYHWD plus WM (TCM-WM group
35 patients) respectively. The effect on anticoagulation was observed and compared. Plasma levels of thromboxane B2 (TXB2 )
6-keto-prostaglandin F1α (6-K-PGF1α)
endothelin (ET)
calcitonin gene related peptide (CGRP) were determined before and after treatment
at the reducing dose and shifting to maintenance dose of prednisone. The therapeutic effect of the two groups were also observed. Another group of 30 healthy subjects was established for control.Results: The differences of TXB2
6-K-PGF1α
ET and CGRP between patients and healthy subjects were very significant before treatment (P < 0. 001). The above-mentioned 4 parameters improved synchronously with the clinical improvement in the therapeutic course and they were better in the TCM-WM group than those in the WM group (P < 0.001 )
and the complete remission rate of the former group was also higher than that of the latter (62.9 % vs 37.1 %
χ2 = 4.63
P < 0.05).Conclusion: BHD could improve the therapeutic effect in treating PNS through the mechanism of improving TXB2
6-K-PGF1α
ET and CGRP levels.
关键词
Buyang Huanwu Decoctionprimary nephrotic syndromethromboxane B26-keto-prostaglandin F1αendothelincalcitonin gene related peptide
Keywords
Buyang Huanwu Decoctionprimary nephrotic syndromethromboxane B26-keto-prostaglandin F1αendothelincalcitonin gene related peptide
references
Wang R, Tang R, Yue XY. Changes of plasma TXB2, 6-K-PGF1α level of diabetic nephropathy patients and its clinical significance. J Chin Nephrol 1992; 8(5):275–276.
Wu YS, Yang JH, Luo NP, et al. The effect of Buyang Huanwu decoction in ET, CGRP of chronic nephritis. J Anhui College of TCM 1998;17(3):12–13.
Feng L, Huang J, Lin ZQ. The relationship between renal blood flow of diabetes mellitus patients and ET, CGRP. J Chin Nephrol 1998;14(1):37–38.
Wang HY, Zheng FL, Liu YC, et al. Minutes of symposium on typing, treatment and diagnostic standard of primary glomerulonephropathy. J Chin Int Med 1993; 32(2):131–134.
Yu XQ, Li HQ, Ye RG, et al. The change of ET in chronic nephropathy and its significance. J Chin Nephro 1995;11(1):91–92.
Ma XF, Zhang TJ. The current status on applying of CGRP in cardiovascular diseases and its prospect. Prog Cardiol 1993; 14(6):360–361.
Han YL, Chen SC. The molecular and cellular mechanism in regulating cardiovascular function by endothelin. Prog Cardiolo 1994; 15(6): 362–363.
Ma LJ, Shen YP, Gao J, et al. The function of endothelin to glomerulo-mesenterial cell inflammatory effect. J Chin Nephrol 1993;9(4):226–228.
Deng CQ, Ge JW, Wang Q, et al. The comparison of effect on Astragalus and activating blood circulation recipe on TXA2, PGI2 of rabbit brain reperfusion injury and on cyclonucleotide. CJIM 1995; 15(3): 165–167.
Zhang YK, Wang HY, Wang SX, et al. Experimental study on Astragalus and Angelica in treating three different pathological types of nephritis. J Chin Int Med 1986; 25(4):222–223.
Clinical study on influence of Buyang Huanwu Decoction on the metabolic imbalance of endothelin and calcitonin gene related peptide in patients with early cerebral infarctionon the metabolic imbalance of endothelin and calcitonin gene related peptide in patients with early cerebral infarction
Buyang Huanwu Decoction (补阳还五汤) reduces infarct volume and enhances estradiol and estradiol receptor concentration in ovariectomized rats after middle cerebral artery occlusion
Effect of qi-tonifying and stasis-eliminating therapy (益气活血法) on expression of vascular endothelial growth factor and its receptors Flt-1, Flk-1 in the brain of intracerebral hemorrhagic rats
Effects of Corocalm (Shuguan Capsule, 疏冠胶囊) on acute myocardial ischemia in anesthetized dogs
Effects of Qindan Capsule (芩丹胶囊) on blood pressure, endothelin, calcitonin gene-related peptide and angiotensin-II in spontaneous hypertensive rats
Related Author
No data
Related Institution
Jinan Municipal Hospital of TCM
Key Laboratory of Internal Medicine, Hunan University of Traditional Chinese Medicine
Department of Neurobiology, Xiangya Medical College, Central South University
Department of Neurology, Xiangya Hospital, Central South University
Institute of the Integration of Traditional Chinese Medicine and Western Medicine, Xiangya Hospital, Central South University